Science in Sport Approves Acquisition by Einstein Bidco

Science In Sport ( (GB:SIS) ) just unveiled an announcement.

Science in Sport (SiS) announced the approval of a recommended cash acquisition by Einstein Bidco Limited, a company indirectly owned by bd-capital Partners Limited. The acquisition, which will be executed through a scheme of arrangement, received the necessary shareholder approvals at both the Court Meeting and General Meeting. This development marks a significant step in the acquisition process, with the final court sanction expected on 12 June 2025. The acquisition is anticipated to impact SiS’s market position by aligning with bd-capital’s strategic interests, potentially benefiting stakeholders through enhanced resources and market reach.

Spark’s Take on GB:SIS Stock

According to Spark, TipRanks’ AI Analyst, GB:SIS is a Neutral.

Science In Sport faces considerable financial challenges with losses and declining revenue, which weigh heavily on the score. However, technical analysis shows strong momentum, and the acquisition by Einstein Bidco Limited offers a strategic improvement. The unattractive valuation due to negative earnings is a concern, but the acquisition brings optimism for future growth.

To see Spark’s full report on GB:SIS stock, click here.

More about Science In Sport

Science in Sport (SiS) operates in the sports nutrition industry, providing products designed to enhance athletic performance and recovery. The company focuses on developing and marketing a range of nutritional supplements and energy products aimed at athletes and fitness enthusiasts.

Average Trading Volume: 561,900

Technical Sentiment Signal: Hold

Current Market Cap: £76.67M

Find detailed analytics on SIS stock on TipRanks’ Stock Analysis page.